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ABSTRACT
 للاخ  نم  ةلوذبلما  ينجورتسلاا  نومره  ريثأت  ةسارد  :فادهلأا
 ىلع  )NTS(  ةدرفلما  ةاونلا  ليبس  يف  يتاذلا  للاقتسلاا  ماظن
 مدلا طغض عافترا فورظ لظ يف يبصعلا ماظنلا ةيساسح ةدايز
.ضيبلما ةلصأتسم نارئفلا يف دالحا
 مولعلل  نامرك  ةعماج  يف  ةيبيرتج  ةسارد  تيرجأ   :ةقيرطلا
 ربوتكأ ىلإ م2010 سرام نم ةرتفلا للاخ ناريإ ،نامرك ، ةيبطلا
 مث نمو ضيبلما ةلصأتسم ىثنأ نارئف 36 ىلع تلمتشاو ،م2010
 ،ينعوبسأ دعب .ينجورتسلاا نومره دللجا تتح تلاوسبك عرز تم
 خض  قيرط  نع  نايرشلاو  ديرولا  يف  رسيلأا  ذخفلا  ىنقم  تم
 تابرض  لدعمو  ينايرشلا  طغضلا  لدعم  ليجستو  نيرفيلينيف
 لولحمو  لولوناربوربو  ،ينبورتلأا  نقح  تم  كلذ  دعبو  .بلقلا
 يف  تاريغتلا  سايق  تم  كلذ  دعب  ،ةدرفلما  ةاونلا  ليبس يف  يحلم
 برست لبق ينايرشلا طغضلا يف تاريغتلاو بلقلا تابرض لدعم
.نيرفيلينيف
 يذلاو  ينجورتسلاا  نومره  يف  عافترا  كلانه  تناك   :جئاتنلا
 ،نيرفيلينيف خض دعب يأ ينايرشلا طغضلا لدعم عافترا نم عنيم
 ةعومجم  يف  ريثكب  لقأ(  بلقلا  تابرض لدعم  يف  ريغتلا  ناك
 .)p>0.05( مكحتلا ةعومجم عم ةنراقم ةلبقتسلما ينجورتسلاا
 ينجورتسلاا  ةعومجم  يف  يبصعلا  ماظنلا  ةيساسح  تعفترا
 ناك  امك  .)p>0.01(  مكحتلا  ةعومجم  عم  ةنراقم  ةلبقتسلما
 يتعومجم ىدل سوملم لكشب نهولما يبصعلا ماظنلا ةيساسح
 ةنراقم  ينبورتلأا  نقح  دعب  )دهاشلاو  ةلبقتسلما  ينجورتسلاا(
.)p>0.01( يحلم لولحم نقح دعب وأ لولوناربورب
 ،دالحا مدلا طغض عافترا فورظ لظ يف هنأ لمتلمحا نم  :ةتماخ
 صاخ ماظن للاخ نم NTS ىلع ريثأت هل امم ينجورتسلاا نومرهو
.يبصعلا ماظنلا ةيساسح ززعيو يواتبمسلا زاهلجاب
Objective: To investigate the effect of estrogen exerted 
through the autonomic system in the nucleus tractus 
solitarii (NTS) on increasing the sensitivity of the 
baroreflex under conditions of acute hypertension in 
ovariectomized rats.
Methods: In this experimental study, conducted in 
Kerman University of Medical Sciences, Kerman, 
Iran from March 2010 to October 2010, 36 female 
rats were ovariectomized and then estrogen capsules 
were implanted beneath their skin. After 2 weeks, 
the left femoral vein and artery were cannulated for 
phenylephrine infusion and recording of mean arterial 
pressure and heart rate. Subsequently, atropine, 
propranolol, and saline were injected into the NTS, 
followed by measurements of changes in heart rate 
and changes in mean arterial pressure just prior to 
phenylephrine infusion. 
Results: Estrogen increased the bradycardia response 
and inhibited the rise of mean arterial pressure; 
namely, after phenylephrine infusion, the change 
in heart rate was significantly lower in the estrogen-
receiving group compared with the control group 
(p<0.05). Baroreflex sensitivity was significantly 
increased in the estrogen-receiving group compared 
with the control group (p<0.01). Baroreflex sensitivity 
was significantly attenuated in both groups (estrogen-
receiving and control) after atropine injection, 
compared with after propranolol or saline injection 
(p<0.01). 
Conclusion: It is probable that under conditions of 
acute hypertension, estrogen affects the NTS through 
the parasympathetic system and enhances baroreflex 
sensitivity.
Neurosciences 2013; Vol. 18 (2): 126-132 
From the Department of Physiology (Pourshanazari), Isfahan 
University of Medical Sciences, Isfahan, the Neuroscience Research 
Center (Tajadini), Kerman University of Medical Sciences, Kerman, 
Iran, and the Department of Physiology and Pharmacology (Ciriello), 
Medical Sciences Building, University of Western Ontario, London, 
Ontario, Canada.
Received 2nd July 2012. Resubmitted 9th January 2013. Accepted 
20th January 2013.
Address correspondence and reprint request to: Dr. Haleh Tajadini, 
Neuroscience Research Center, Kerman University of Medical Sciences, 
Kerman, Iran. Tel. +98 (341) 2263815. Fax. +98 (341) 2263855. 
E-mail: h_tajadini@kmu.ac.ir / swt_f@yahoo.com 
Articles
126 Neurosciences 2013; Vol. 18 (2)     www.neurosciencesjournal.org
127     Neurosciences 2013; Vol. 18 (2) 
17-b estradiol on baroreflex sensitivity … Pourshanazari et al
www.neurosciencesjournal.org
Hypertension is among the most serious challenges of modern societies. It is a common and 
asymptomatic disease, which is easy to diagnose 
and treat; however, if untreated, it results in fatal 
complications.1 The prevalence of hypertension in 
women is closely related to age,2 increasing considerably 
after the age of 50 through an unknown mechanism.1 
An appropriate systemic arterial pressure is the only 
requirement for optimal cardiovascular function.3 
Arterial pressure is persistently monitored3 by different 
receptors throughout the body.4 The baroreceptor reflex 
is among the short-term regulators of arterial pressure.4 
This reflex starts at the site of tension receptors (called 
baroreceptors) in the wall of systemic arteries. The 
afferent fibers terminate mostly at the nucleus tractus 
solitarii (NTS).5,6 According to the previous studies, the 
fatality of cardiovascular disease is greater in menopausal 
women and men compared with women before 
menopause.7-10 The NTS is at the main terminal point 
for visceral afferent fibers of the brainstem and plays an 
essential role in regulating cardiovascular function.6,11-
14 A study by Saleh and Connell et al15 indicated that 
direct infusion of estrogen in the central nuclei of 
male rats caused significant changes in autonomic and 
cardiovascular parameters.15 
Sexual differences influence the neuro-humoral 
control of the cardiovascular system with women having 
a more prominent vagal tone and thus less fatality 
compared with men.11 Estrogen enhances the baroreflex 
sensitivity (BRS) under acute conditions and inhibits 
dramatic changes of the mean arterial pressure (MAP), 
thus preventing its abrupt increase, as well as intensifying 
the bradycardia reflex caused by phenylephrine (PE) in 
rats.16 Estrogen infusion in the central nuclei controlling 
the cardiovascular system contributes to processing 
and summarizing of autonomic responses.15 Estrogen 
increases the BRS considerably and blocks the attenuated 
BRS following vagal stimulation.16 It also decreases 
the neural stimulation in the parabrachial nucleus 
(PBN) through modifying the synaptic transmission 
via increasing the release of gamma aminobutyric acid 
(GABA) and decreasing the release of glutamate.17 
This substance enhances vagal activity and attenuates 
renal nerve activity resulting in enhanced baroreflex 
sensitivity and modifies the base autonomic tone via the 
activity of central estrogen receptors.18 Our experiments 
indicate that estrogen affects the BRS mostly through 
the parasympathetic component of the autonomic 
system in the NTS. The results of previous studies 
indicate that the autonomic inductions of estrogen on 
the PBN affect the glutamate receptors to decrease heart 
rate (HR) and increase the parasympathetic tone, while 
it reduces blood pressure and sympathetic activity by 
affecting the GABA receptors.19
Considering these facts and the prominent role of 
the autonomic system in regulating the cardiovascular 
system, as well as the role of the NTS in this regard, 
it is probable that estrogen enhances BRS through the 
autonomic system in the NTS under conditions of acute 
hypertension. Previous studies have proven the role of 
the NTS in controlling acute hypertension in animals.20 
Nervous stimulations from baroreceptors of the aorta 
and carotid arrive at the NTS and from there, the 
inhibitory effects are dispatched to various parts of the 
brainstem, resulting in decreased sympathetic flow and 
thus reduced blood pressure.21 However, damage of the 
NTS reduces baroreflex control of the blood pressure, 
leading to increased sympathetic activity and severe 
hypertension.22 Arterial pressure is controlled by the 
autonomic nervous system and the impulses generated 
in visceral receptors are transmitted to the CNS via 
the autonomic afferent pathway to be summarized in 
different levels and then transmitted to the operating 
organs via the efferent pathways.5 One issue that has been 
investigated is the role of sex hormones in controlling 
blood pressure.23 Previous studies have indicated that 
hormones secreted by the gonads contribute to the 
control of blood pressure in rats.21 This finding resulted 
in introduction of sex hormone replacement therapy,22,23 
which entailed controversial opinions.24 A series of 
experiments indicated that ovariectomy renders the 
animal subject to hypertension, which was not related 
to the sodium content of its diet.25-27 According to the 
research data, estrogen is synthesized and released in the 
brain,28,29 and there are estrogen receptors in the central 
autonomic nuclei.30
Measurements of BRS indicates BRS to be greater 
in women before menopause compared with men 
of the same age and menopausal women.16,31,32,33 The 
central mechanisms of these effects, however, remain 
to be discovered. In our previous study, we indicated 
that estrogen enhances the BRS via the autonomic 
system in male rats.34 The objective of the present 
study was to investigate the mechanism of estrogen 
effect on autonomic activity of the NTS in female rats 
following ovariectomy, in order to provide a basis for 
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understanding the protective cardiovascular effects of 
estrogen and its central mechanisms.
Methods. This is experimental study was conducted 
in Kerman University of Medical Sciences, Kerman, 
Iran from March 2010 to October 2010. The study 
protocol was approved by Research Deputy at Kerman 
University of Medical Sciences, Kerman, Iran.
We used 6 groups of animals, each with 6 rats, 
yielding a total of 36 laboratory rats. Our animals were 
2 month old albino Wistar rats with an average weight 
of 250±50 g. All rats were preserved under standard 
laboratory conditions in the vivarium of Rafsanjan 
University of Medical Sciences. After ovariectomy, 
the rats were divided into 2 groups: one receiving 
estrogen (18 rats) and one receiving sesame oil (18 
rats, the control group). Subsequently, each group was 
subdivided into 3 groups for microinjection of each of 
the 3 drugs: atropine, propranolol, and saline into the 
NTS. The experiment was performed in the following 
stages:
Anesthesia. The rats were put under anesthesia in 2 
stages. The first stage was for implanting the capsules 
and ovariectomy, performed with intra-peritoneal 
injection of 150 mg/kg of ketamine, causing transient 
anesthesia. In the second stage, performed 2 weeks later 
for cannulation in order to provide access to the NTS, 
150 mg of urethane per 100 g body weight was injected 
intra-peritoneally and an extra dose (10 mg per 100 g 
body weight) was used, if required.21
Capsule implant. A silastic capsule 3.8 mm in 
diameter, 30 mm in length, and 0.07 mL in volume 
was implanted subcutaneously. A small incision was 
made on the nape and the capsule containing estrogen 
or sesame oil (as dissolvent), was planted under the 
skin. Thus, the animals fell into either of the 2 groups: 
receiving estrogen or receiving sesame oil.15
Ovariectomy. Two weeks prior to cannulation, 
bilateral incisions of 2-3 centimeters were made on the 
flanks of the rats to dissect the skin and muscles, revealing 
the ovaries. Subsequently, the ovaries were dissected and 
muscles and skin were repaired separately.26
Cannulation. In order to facilitate respiration during 
anesthesia, a PE240 cannula was inserted in the trachea. 
The left femoral artery and vein were cannulated using 
PE50 cannulae containing saline and heparin (200 
u/mL). The venous and arterial cannulae were used for 
drug infusion and pressure recording. Therefore, the 
arterial cannula was attached to a pressure transducer.21
Access to the NTS for microinjection of drugs. 
After cannulation, the animals were transferred to 
a stereotaxic instrument (Stoelting, Wood Dale, IL, 
USA). The posterior surface of the medulla was exposed 
by craniotomy. The landmarks of the NTS were traced 
using a Paxinos Atlas. The scriptorius was considered as 
the reference point and microinjection of the drugs was 
performed at this point.23
Microinjection of drugs in the NTS. Three groups 
were treated with 3 microinjections into the NTS: 1) 
atropine as a muscarinic inhibitor, 2) propranolol as a 
b-blocker, and 3) saline as placebo. Drugs were injected 
by pressure.
Recording pressure and heart rate. The arterial 
cannula containing saline and heparin was attached to 
a pressure transducer to record pressure. The pressure 
curve, consisting of systolic and diastolic pressures, was 
recorded and the data generated by a tachograph and 
an analyzer was processed with Power lab and HRs and 
MAP were calculated.
Investigating baroreflex sensitivity. For this purpose, 
PE was used as a vessel constrictor to cause abrupt 
hypertension. Following administration of PE, the 
ratio of the peak changes in the magnitude of the 
reflex bradycardia (the change in HR or ΔHR) to the 
magnitude of the PE-induced pressor response (the 
change in MAP or ΔMAP) was calculated as an index 
for BRS.15
Controlling the sites of microinjection with 
histological sections (exclusion criterion). At the end of 
the experiment, the brains were extracted, fixated by 
10% formalin, and frozen sections of the NTS were 
prepared with thicknesses of 40 μm. The slides were 
compared for the landmarks depicted in the Paxinos 
Atlas, and in case of incompatibility, they were discarded 
and their data were excluded from the analysis (Figure 
1).
Statistical analysis. To compare BRS before and 
after intervention, the paired t-test was used. The means 
of groups were compared using analysis of variance 
(ANOVA) and Tukey’s test was used as a post-hoc test. 
The Statistical Package for Social Sciences (SPSS Inc., 
Chicago, IL, USA) version 15.00 for Windows was 
used for data analysis, and p-values equal or less than 
0.05 were considered significant. 
Results. As Table 1 depicts, there is no statistically 
significant difference between the systolic and diastolic 
blood pressure and the MAP of the estrogen-receiving 
group and the control group. In other words, both 
groups of rats were hemodynamically normal and 
identical in terms of systolic and diastolic blood pressure 
and MAP prior to the condition of acute hypertension. 
Furthermore, as the table illustrates, there was no 
statistically significant difference between the HR of 
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receiving group to 0.33±0.03 in the atropine-receiving 
group, indicating that in the ovariectomized rats of the 
control group, BRS decreases after infusion of atropine 
compared to the infusion of propranolol and saline 
(p=0.0457). Figure 4 indicates that BRS in the estrogen-
receiving ovariectomized rats decreases from 1.61±0.2 in 
the saline receiving group and 1.65 in the propranolol-
receiving group to 0.8±0.09 in the atropine-receiving 
group. Thus, the BRS of the estrogen-receiving 
Figure 1 - Presentation of the histological sections from the nucleus 
tractus solitarii of ovariectomized rats where the solid circles 
represent the site of atropine microinjection, solid triangles 
represent the site of propranolol microinjection, and hollow 
circles represent the site of saline microinjection. The negative 
numbers on the left depict the distance of the incision from 
the interaural line according to the Paxinos Atlas. cu - nucleus 
cuneatus, gr - nucleus gracilis
Figure 2 - Comparison of the baroreflex sensitivity (ΔHR/ΔMAP) 
between the control group and the case group (receiving 
estrogen) in ovariectomized rats. **p=0.009. HR - heart rate, 
MAP - mean arterial pressure
Figure 3 - Comparison of the baroreflex sensitivity in the control group 
(saline microinjection) versus the propranolol and atropine 
groups in the nucleus tractus solitarii of ovariectomized rats. 
*p=0.0457
Figure 4 - Comparison of the baroreflex sensitivity in the estrogen-
receiving group (saline microinjection) versus the propranolol 
and atropine groups in the nucleus tractus solitarii of 
ovariectomized rats. *p=0.0084
Table 1 - Comparison of the mean systolic and diastolic blood pressure, 
mean arterial pressure, and heart rate in ovariectomized rats in 






















The above factors were compared between the estrogen
and the control groups using paired t-test
both groups before infusion of PE; namely, just prior to 
the condition of acute hypertension, both groups of rats 
were hemodynamically normal and identical in terms 
of HR.
As may be seen on Figure 2, the baroreflex sensitivity 
of ovariectomized rats enhanced from 0.51±0.06 to 
1.52±0.26 in the estrogen-receiving group, indicating 
an increased sensitivity of baroreflex sensitivity in the 
estrogen-receiving group compared with the control 
group (p=0.009). Figure 3 depicts that the BRS of the 
ovariectomized rats in the control group (receiving 
sesame oil) decreased from 0.52±0.07 in the saline 
receiving group and 0.63±0.08 in the propranolol 
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ovariectomized rats decreases after infusion of atropine 
compared with the infusion of saline and propranolol 
(p=0.0084).
Discussion. Our study is one step towards resolving 
cardiovascular problems through sex hormones. In 
this study, we indicated systolic and diastolic blood 
pressure, as well as the MAP and HR to be similar 
in ovariectomized rats prior to PE injection in both 
groups receiving estrogen or sesame oil; in other words, 
before the conditions of acute hypertension, all rats 
in the estrogen or sesame oil receiving groups were 
hemodynamically normal and similar in terms of MAP 
and HR. Following the injection of PE (16 μg/kg), 
the change in HR decreased in the estrogen-receiving 
groups compared with the control group.
In the estrogen-receiving group, infusion of PE with 
the same dose resulted in severe decrease of heart rat; in 
other words, estrogen intensifies the bradycardia reflex 
caused by PE in rats. The change in HR was different 
between the estrogen group and the control group. 
Following the infusion of PE and establishment of 
acute hypertension, the MAP increased in the control 
group. In the estrogen-receiving group, the same 
scenario caused a decrease in MAP and the change in 
MAP was decreased in the estrogen group compared 
with the control group. Therefore, estrogen suppresses 
dramatic changes of MAP under acute conditions and 
prevents its abrupt rise; a finding that is in line with that 
of Saleh and Connell15 who injected estrogen into the 
central nucleus amygdala to increase the baroreceptor 
reflex. According to previous studies, estrogen enhances 
the BRS considerably,16 and induces resistance against 
autonomic disorders.35
In the present study, the BRS is considerably higher 
in the estrogen-receiving ovariectomized rats compared 
with the group receiving sesame oil. We compared the 
BRS in each of the control and estrogen-receiving groups 
under 3 conditions of atropine, propranolol, and saline 
microinjection into the NTS to discover that BRS in the 
estrogen group is considerably higher compared with 
the group receiving sesame oil. Baroreflex sensitivity has 
been widely accepted as a tool for clinically diagnosing 
people at risk of cardiovascular diseases. It has been 
demonstrated clinically that women with cardiovascular 
diseases have considerably lower serum levels of estrogen 
compared with healthy women of similar ages.36 Even 
in various stages of the menstrual cycle and pregnancy, 
the autonomic tone and the reflex controlling the 
autonomic function depend on the plasma levels of 
estrogen.37 In a study by Goldman et al18 a single dose 
of estrogen caused significant changes in BRS. In other 
studies, supplementary estrogen reduced blood pressure 
by decreasing the activity of the renal nerve, dilating 
the vessels, and reducing stress-induced hypertension.38 
Following acute estrogen induction, BRS decreases as 
well as the sympathetic tone.37
Estrogen injection into other cerebral nuclei, 
such as the PBN, induces changes in autonomic and 
cardiovascular parameters. It particularly reduces 
MAP, HR and the sympathetic tone while increasing 
the parasympathetic tone. Microinjection of 17-b 
estradiol into the PBN suppresses the membrane 
stimulation and modifies the transmission of visceral 
signals to the ventrobasal nucleus of thalamus, inducing 
its autonomic effects.17,39 We observed the effect of 
estrogen intensifying the bradycardia reflex caused by 
PE. We also noticed that estrogen enhances the BRS 
through the autonomic system in the NTS, particularly 
the parasympathetic system.
One advantage of the present study is the 
subcutaneously implanted capsule of estrogen, which 
releases estrogen to the bloodstream with a constant 
dose, acting like a natural gland. Previous studies, 
however, used subcutaneous or intra-peritoneal 
injection of estrogen, which results in reduction of the 
hormone concentration over time without maintaining 
a constant level in bloodstream. The findings of 
the present study indicate that the NTS affects the 
BRS through the autonomic system. It may also be 
concluded that estrogen enhances the bradycardia reflex 
and inhibits the rise in MAP “under conditions of 
acute hypertension” as well as the increased BRS in the 
estrogen group compared with the control group.
Our findings also indicate that the effects of NTS on 
BRS are primarily exerted through the parasympathetic 
system, since atropine reduced BRS via the muscarinic 
receptors and inhibition of the parasympathetic system. 
Atropine microinjection in the NTS reduced the BRS, 
whereas propranolol or saline microinjection had no 
effect on BRS. Therefore, NTS does not affect the 
BRS through the sympathetic system and the role of 
b-adrenergic receptors is minimal in this region, while 
the presence and role of muscarinic receptors are greater 
in the NTS.
The findings of this study are consistent with those 
of our previous study on male rats, indicating similar 
mechanisms in both genders of the animal, thus 
highlighting the values of hormone therapy.34
In conclusion, it is probable that estrogen affects the 
NTS via the parasympathetic system under conditions 
of acute hypertension, leading to increased BRS. 
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These findings may indicate the advantage of estrogen 
therapy/hormone therapy. Therefore, it is essential to 
conduct further studies on the autonomic system in 
other cerebral nuclei.
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